HomeIMVT • NASDAQ
add
Immunovant Inc
Previous close
$20.60
Day range
$18.13 - $20.69
Year range
$18.13 - $35.97
Market cap
3.13B USD
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 114.30M | 85.70% |
Net income | -111.12M | -116.11% |
Net profit margin | — | — |
Earnings per share | -0.76 | -111.11% |
EBITDA | -114.20M | -85.71% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 374.68M | -45.77% |
Total assets | 420.93M | -40.83% |
Total liabilities | 68.32M | 112.81% |
Total equity | 352.62M | — |
Shares outstanding | 169.86M | — |
Price to book | 8.58 | — |
Return on assets | -61.02% | — |
Return on capital | -71.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -111.12M | -116.11% |
Cash from operations | -100.39M | -113.15% |
Cash from investing | -180.00K | -37.40% |
Cash from financing | 2.46M | -99.48% |
Net change in cash | -98.26M | -123.34% |
Free cash flow | -61.61M | -77.11% |
About
Founded
2018
Website
Employees
207
